The move is the latest recruiting win for RBC Wealth Management as it continues to lure top talent away from big banks and brokerage firms.

J.P. Morgan analyst Anthony Paolone maintained a Buy rating on W. P. Carey Inc. (WPC – Research Report) on January 16 and set a price target of

In a report released today, Javier Garrido from J.P. Morgan maintained a Hold rating on Orsted (DOGEF – Research Report), with a price target

While Biogen has made an opportunistic bid for partner Sage, its top executive seemed to play down the urgency for his company to go after larger deals.

NFJ Investment Group CIO John Mowrey reacts to real estate giant Brookfield defaulting on $161 million mortgage for office properties on 'The Claman Countdown.' Carnivore Trading CEO Dutch Masters and Prosper Trading Academy CEO Scott Bauer discuss whether banking anxieties are overblown on 'The Claman Countdown.

Doug Petno, Troy Rohrbaugh and Marianne Lake are the three top contenders to succeed JPMorgan Chase CEO Jamie Dimon, according to a report.

SmartCentres Real Estate Investment Trust ("SmartCentres" or the "Trust") announced today that it has priced an offering of $300 million aggregate principal amount of 4.737% Series AB senior unsecured debentures on an agency basis.

"Fixed income is beginning 2025 where it left off 2024, which is to say yields are moving higher," said Daryl Clements, a municipal portfolio manager at AllianceBernstein.

Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.

Analysts are evaluating the financial impact of the wildfires that have charred hillsides, homes and streets in Los Angeles County, with initial estimates from AccuWeather suggesting total economic losses could reach as high as $150 billion.

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar depression.

On Thursday, RBC Capital Markets adjusted its outlook on shares ... With a market capitalization of $709.92 billion and a P/E ratio of 12.93, JPM has maintained dividend payments for 55 ...